LumiraDx Limited

NASDAQ:LMDX   2:49:34 PM EDT
1.10
+0.03 (+2.80%)
Products, Expansion

Lumiradx Continues Commercial Expansion Of Its Rapid Microfluidic Immunoassay HbA1c Test

Published: 11/14/2022 08:07 GMT
LumiraDx Limited (LMDX) - Lumiradx Continues Commercial Expansion of Its Rapid Microfluidic Immunoassay Hba1c Test.
Lumiradx Expanding Hba1c Test in Europe, Parts of the Middle East, Asia, Latin America, and Africa.